All Topics
All Topics
Technology
Technology
Design
Design
Programming
Programming
Science
Science
News
News
Gaming
Gaming
Entertainment
Entertainment
Business
Business
Finance
Finance
Sports
Sports
Health
Health
Food
Food
Travel
Travel
Art
Art
Music
Music
Books
Books
Education
Education
Politics
Politics
Personal
Personal
Bluesky
Twitter
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

ProPublica Investigation Reveals How Drugmaker's Price Hikes Made a $0.25 Pill Cost Nearly $1,000

11h ago· 1 min readenNews

Summary

Reporter David Armstrong, diagnosed with cancer, investigates why one of his prescribed drugs costs nearly $1,000 per pill. Through financial records and legal filings, he uncovers a drugmaker's deliberate strategy of repeatedly raising prices, which helps explain why the U.S. healthcare system is the most expensive in the world. The article is based on ProPublica's reporting about Revlimid, a multiple myeloma drug.

Key quotes

· 3 pulled
Reporter David Armstrong was diagnosed with cancer and soon learned that one of his drugs would cost almost $1,000 per pill.
He set out to discover why, and uncovered financial records and legal filings that shocked him.
The drugmaker's strategy to raise the price over and over again helps explain why our healthcare system is the most expensive in the world.
Snippet from the RSS feed
Podcast Episode · Paper Trail · June 11 · 41m

You might also wanna read